Regulatory updates are needed to prevent the commercialization of islet transplantation in the United States

Piotr Witkowski; Rolf N Barth; Anthony Japour; Gail Javitt; Jordan S Pyda; Piotr J Bachul; Eryk Nowicki; Camillo Ricordi; “Islet for US Collaborative”

doi:10.1111/ajt.16555

Regulatory updates are needed to prevent the commercialization of islet transplantation in the United States

Am J Transplant. 2021 Jul;21(7):2620-2622. doi: 10.1111/ajt.16555. Epub 2021 Mar 20.

Authors

Piotr Witkowski¹, Rolf N Barth¹, Anthony Japour², Gail Javitt³, Jordan S Pyda⁴, Piotr J Bachul¹, Eryk Nowicki⁵, Camillo Ricordi⁶; “Islet for US Collaborative”

Affiliations

¹ Department of Surgery, Transplantation Institute, University of Chicago, Chicago, Illinois.
² Anthony Japour and Associates, Medical and Scientific Consulting Inc, Miami, Florida.
³ Hyman, Phelps & McNamara P.C., Berman Institute of Bioethics, Johns Hopkins, Baltimore, Maryland.
⁴ Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
⁵ S.W.C Nowicki, Chicago, Illinois.
⁶ Diabetes Research Institute and Cell Transplant Center, University of Miami, Miami, Florida.

PMID: 33683809
DOI: 10.1111/ajt.16555

No abstract available

Keywords: diabetes: type 1; editorial/personal viewpoint; ethics and public policy; insurance - public; islet transplantation; islets of Langerhans; law/legislation; quality of care/care delivery.

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Diabetes Mellitus, Type 1*
Humans
Islets of Langerhans Transplantation*
Islets of Langerhans*
United States

Grants and funding

P30DK020595/DK/NIDDK NIH HHS/United States